Local Probiotic Therapy for Vaginal Candida albicans Infections (Q41681212)

7 October 2017

title

Local Probiotic Therapy for Vaginal Candida albicans Infections (English)

1 reference

7 October 2017

0 references

1 reference

Stefan Miladinov Kovachev

series ordinal

1

1 reference

7 October 2017

Rossitza Stefanova Vatcheva-Dobrevska

series ordinal

2

1 reference

7 October 2017

publication date

1 March 2015

1 reference

Probiotics and antimicrobial proteins

7 October 2017

published in

1 reference

7 October 2017

volume

7

1 reference

7 October 2017

issue

1

1 reference

7 October 2017

page(s)

38-44

1 reference

Survey of vaginal-flora Candida species isolates from women of different age groups by use of species-specific PCR detection

7 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Correlation between azole susceptibilities, genotypes, and ERG11 mutations in Candida albicans isolates associated with vulvovaginal candidiasis in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Antifungal susceptibilities of Candida species causing vulvovaginitis and epidemiology of recurrent cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Improved treatment of vulvovaginal candidiasis with fluconazole plus probiotic Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Fluconazole susceptibility of vaginal isolates obtained from women with complicated Candida vaginitis: clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Probiotic interference of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 with the opportunistic fungal pathogen Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

The in vitro activity of vaginal Lactobacillus with probiotic properties against Candida

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Effect of Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri RC-14 on the ability of Candida albicans to infect cells and induce inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Induction of mucosal immune responses in the human genital tract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Probiotic lactobacillus and estrogen effects on vaginal epithelial gene expression responses to Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Characterization of pentocin TV35b, a bacteriocin-like peptide isolated from Lactobacillus pentosus with a fungistatic effect on Candida albicans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Effect of lactobacillus in preventing post-antibiotic vulvovaginal candidiasis: a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Effectiveness of the association of 2 probiotic strains formulated in a slow release vaginal product, in women affected by vulvovaginal candidiasis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S12602-014-9176-0

Lactobacillus GG vaginal suppositories and vaginitis

21 January 2018

1 reference

12 December 2020

[Role of Lactobacillus as protector against vaginal candidiasis]

1 reference

12 December 2020

Selection and identification of anaerobic lactobacilli producing inhibitory compounds against vaginal pathogens

1 reference

12 December 2020

Sexually transmitted diseases treatment guidelines, 2010

1 reference

12 December 2020

The in vitro effect of hydrogen peroxide on vaginal microbial communities

1 reference

12 December 2020

Probiotic Lactobacillus dose required to restore and maintain a normal vaginal flora

1 reference

12 December 2020

Vaginal candidiasis--treatment protocols using miconazole and fluconazole

1 reference

12 December 2020

In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis

1 reference

12 December 2020

Comparative study of itraconazole and fluconazole therapy in vaginal candidosis

1 reference

12 December 2020

Combined single-day treatment in acute vulvovaginal candidosis

1 reference

12 December 2020

10.1007/S12602-014-9176-0

Identifiers

DOI

1 reference

7 October 2017

1 reference